IMA | AI Transformation Index
IMA is a structurally durable industrial machinery business whose physical delivery model, regulatory moats, and installed-base lock-in make it highly resi...

Overview
IMA Group designs, engineers, and manufactures highly specialized automated processing and packaging machinery for pharmaceutical, food, cosmetics, and consumer goods customers globally, generating revenue through capital equipment sales, long-term service contracts, spare parts, and after-sales support.
Executive Summary
IMA is a structurally durable industrial machinery business whose physical delivery model, regulatory moats, and installed-base lock-in make it highly resistant to the AI disruption threatening cognitive-labor-intensive services businesses — AI strengthens rather than erodes IMA's physical-asset advantage as cognitive barriers elsewhere dissolve. The AI opportunity is real but moderate: the business is primarily constrained by manufacturing capacity rather than cognitive labor, so AI delivers meaningful efficiency gains in engineering, service, and design without enabling the order-of-magnitude throughput transformation available to pure-play cognitive businesses. For a PE sponsor, IMA is a high-durability, moderate-opportunity asset — the investment thesis is defensibility and steady AI-enabled margin improvement rather than transformative AI-driven upside.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
64.0
Ciridae AI Score
Durability Rationale
IMA's durability is structurally strong and rooted in physical realities that AI cannot dissolve: the customer outcome is a physically installed, GMP-validated industrial machine that requires certified manufacturing, on-site commissioning, and regulatory qualification — none of which an LLM or AI agent can substitute. The pharmaceutical segment adds multiple layers of structural protection through change-control requirements and lengthy machine revalidation, creating switching costs that are operational and regulatory rather than merely economic. As AI lowers barriers in cognitive industries, IMA's physical footprint, deep regulatory track record, and machine-embedded service relationships become relatively stronger moats, not weaker ones.
Opportunity Rationale
AI's impact on IMA is real but structurally bounded by the physical nature of the business — the cognitive labor that AI can dramatically compress represents a meaningful but minority share of total value-creating activity, primarily in engineering design, technical documentation, after-sales diagnostics, and predictive maintenance. The most credible opportunity is AI augmenting IMA's deep proprietary domain intelligence (accumulated machine performance data from thousands of installed units, application-specific engineering expertise) to accelerate R&D cycles and enhance the service offering, rather than transforming the fundamental economics of manufacturing. IMA is already moving in this direction with the AI LAB and Digital Twin initiatives, which partially discounts the unrealized step-change an outside catalyst could unlock.
Key Risks
If AI dramatically accelerates the engineering design and software development cycles of new market entrants — particularly Chinese automation manufacturers who are already cost-competitive — IMA's product development lead time advantage could compress faster than expected, eroding the competitive moat before physical and regulatory barriers fully compensate.
IMA has already launched the AI LAB, Sentinel monitoring platform, and Digital Twin initiatives, meaning it may capture most of the near-term AI opportunity internally without needing external catalysis — which would make the unrealized step-change smaller than it appears from the outside, and the Opportunity score more optimistic than warranted.
Company Overview
| Headquarters | Ozzano dell'Emilia (Bologna), Italy |
| Products / Services | IMA designs and manufactures a wide range of automatic machines and solutions, including: Processing and packaging machines for pharmaceuticals, cosmetics, food, tea, coffee, and tobaccoSpecialized machines such as tea bagging and coffee pod machinesSolid dose manufacturing equipmentSterile processing equipmentLiquid filling machinesFreeze-drying machinesLabelling, blistering, counting, tube filling, end-of-line, and cartoning machinesFlexible packaging solutions and end-of-line packaging solutionsAutomation technologies, including a dedicated Automation division focusing on Life SciencesSustainable packaging initiatives under programs like IMA ZERO, IMA NoP (No-Plastic Programme), and IMA Low (Low-Impact Programme). |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
Leonard Green & Partners and BDT & MSD Partners invest in IMA Group, acquiring stakes from BC Partners; Vacchi family remains majority owner. July 31, 2023 | No specific individuals from Leonard Green & Partners holding senior roles such as Partner, Managing Partner, or Managing Director who led or co-led the July 31, 2023 investment deal in IMA Group were publicly identified. |
Sale of Stake to BDT & MSD Partners July 31, 2023 | BC Partners announced a strategic investment by BDT & MSD Partners, a U.S. merchant bank, acquiring BC Partners' stake in IMA Group. The Vacchi family remained the majority owner of IMA. During BC Partners' ownership, IMA achieved significant growth, including a 70% increase in EBITDA and multiple bolt-on acquisitions. The transaction was positioned to accelerate IMA's growth, especially in sustainable packaging and global expansion. |
Take-private by BC Partners and Vacchi family February 10, 2021 | BC Partners acquired I.M.A. Industria Macchine Automatiche by teaming up with the largest shareholder, the Vacchi family, through a mandatory tender offer. The take-private was completed in February 2021, delisting the company from the Milan Stock Exchange. This was one of the largest take-private deals on a European stock exchange during the COVID-19 pandemic period. |
BC Partners invests and partners with SOFIMA; mandatory tender offer launched to take IMA private. 2020 | BC Partners and Vacchi family acquired full control; IMA Group delisted from Milan Stock Exchange. |
Executives
| Name | Background |
|---|---|
Alberto Vacchi Chairman and Chief Executive Officer (CEO) | Born in Bologna in 1964, graduated in Law (Giurisprudenza). He started working at IMA immediately after graduation and has over 35 years of experience in the company. He has developed a diversified industrial model focusing on teamwork, innovation, and strong labor relations. He led the growth of the family group into diversified sectors including Pharma, Food, and Automation. He initiated extensive digitalization and technological innovation programs. He served as President of Unindustria Bologna (2011-2015) and Confindustria Emilia Area Centro (until 2019). He is a member of the Regional Council of Confindustria Emilia-Romagna and the Bologna Business School advisory board. He is the President of Liceo Steam International in Bologna. He was awarded the Leonardo Quality Italy Prize in 2015 for innovative development and international presence. He was named Knight of Labor in 2018. He received an honorary degree in Management Engineering from Alma Mater Studiorum - University of Bologna in 2023. He also chairs other family-related agricultural and industrial companies. |
Sergio Marzo Director of Finance / Chief Financial Officer (CFO) | Based in Bologna, Italy. Holds a Bachelor of Business Administration (BBA) in Business Administration and Management from the University of Bologna. Over 24 years at IMA Spa as CFO. |
Giovani Pecchioli Chief Operating Officer (COO) | Age 69 as per MarketScreener data. |
Leonard Green & Partners
BC Partners